Takeda receives FDA approval for fruquintinib for certain colorectal cancer patients

Photo: Takeda sign outside the California office/iStock; JHVE Photo The FDA on Wednesday approved Takeda Pharmaceutical’s fruquintinib for adult patients with previously treated metastatic colorectal cancer. Oral targeted therapy for VEGF-1, -2, and -3 receptors carries the brand name Furuzakura. Full Sakura-san label Patients previously treated with fluoropyrimidine, oxaliplatin, irinotecan chemotherapy, and anti-VEGF agents are […]

Tumor microenvironment in colorectal cancer patients

Sponsored content organized gnosticsNovember 1, 2023Review by Maria Osipova Genetic and cellular screens are essential for understanding the genotype and phenotype of specific cells, providing important insights into disease treatment and prognosis. Immunohistochemistry, in particular, when combined with advances in tissue cytometry and gene sequencing, enables detailed analysis of the tumor microenvironment, uncovering the mechanisms […]

Individualized survival planning for colon cancer patients receiving adjuvant chemotherapy

Healthcare providers caring for colon cancer survivors need personalized survival plans for patients that monitor for cancer recurrence while also managing other long-term effects, according to a review published in It is necessary to formulate a clinical colorectal cancer.1 Although colon cancer remains one of the most commonly diagnosed cancers in the United States, the […]

More aggressive treatment has no impact on quality of life for patients with metastatic colorectal cancer, according to new study in JNCCN

Researchers have found that in patients with multivisceral metastatic colorectal cancer, removing as much tumor as possible using various methods does not reduce quality of life, although it increases adverse events. Survival benefits are still unknown. Plymouth Meeting, Pennsylvania, October 12, 2023 /PRNewswire/ — New research in October 2023 Problem of JNCCN—Journal of the National […]